Glucose regulated protein 78 (GRP78) is usually recognized as a chaperone in the endoplasmic reticulum. However, increasing evidence indicates that GRP78 can be translocated to the cell surface, acting as a signaling receptor for a variety of ligands. Since little is known about the secretion of GRP78 and its role in the progression of colon cancer we here focused on GRP78 from colon cancer cells, and purified GRP78 protein mimicking the secreted GRP78 was able to utilize cell surface GRP78 as its receptor, activating downstream PI3K/Akt and Wnt/β-catenin signaling and promote colon cancer cell proliferation. Our study revealed a new mode of action of autocrine GRP78 in cancer progression: secreted GRP78 binds to cell surface GRP78 as its receptor and activates intracellular proliferation signaling.
Introduction
Glucose regulated protein 78 (GRP78) is traditionally regarded as a major molecular chaperone in the endoplasmic reticulum (ER), which facilitates protein folding and assembly, protein quality control, Ca 2+ binding and regulates ER stress signaling. GRP78 is usually overexpressed in tumor cells, and implicated in tumor cell survival, angiogenesis, metastasis and therapy resistance (Lee, 2007; Vlashi et al., 2011; Li and Li, 2012) . GRP78 is also involved in transcriptional activation of proinflammatory cytokine genes and is a valid therapeutic target for prevention of liver cancer (Wang et al., 2014) .
Emerging evidences indicate that GRP78 can be translocated to the cell surface and acts as a receptor for a variety of ligands, exhibiting a wide range of biological effects. Ligation of surface GRP78 by activating α2-macroglobulin (α2-M*) activates MAPK and Aktdependent signaling and promotes cell proliferation of prostate cancer cells (Misra et al., 2006) . Cripto protein can form a complex with GRP78 at the cell surface, inhibiting transforming growth factor signaling and enhancing cell growth (Shani et al., 2008; Kelber et al., 2009) . In addition, cell surface GRP78 promotes colorectal cancer cell migration and invasion, independent of its signaling receptor function (Li et al., 2013) .
Besides its location in the ER and cell membrane, GRP78 has been found present in cytoplasm, mitochondria, nucleus and cellular secretions (Vlashi et al., 2011 (Kern et al., 2009 ). However, other biological roles of secreted GRP78 in tumor microenvironment and its action mode have not been identified.
In the present study, we demonstrate that GRP78 can be secreted from colon cancer cells. Recombinant GRP78 mimicking secreted GRP78 promoted cancer cell proliferation. Interestingly, purified GRP78 could utilize cell surface GRP78 as its receptor, and activate PI3K/ Akt signaling. These findings provide novel insights into understanding biological functions of secreted GRP78.
Materials and Methods

Materials
RPMI-1640 medium and fetal bovine serum (FBS) were from GIBCO (Grand Island, NY). MTT and DAPI were obtained from Sigma (St. Louis, MO). GST affinity resin (glutathione Sepharose 4 Fast Flow) was purchased from GE Healthcare (Uppsala, Sweden). Antibodies for cyclin D1, cyclin E, β-actin and GAPDH were from Bioworld Technology (Minneapolis, MN). Antibodies for p-GSK-3β, p-Akt and Akt were obtained from Cell Signaling Technology (Danvers, MA). Antibodies for GRP78, β-catenin and c-Myc were from Abcam (Cambridge, UK). HRP-conjugated secondary antibodies were obtained from Invitrogen (Carlsbad, CA).
Protein purification and non-denaturing PAGE assay
Cellular RNA was extracted from HT-29 cells using
Rong Fu et al TRIAZOL reagent. The cDNA obtained by reverse transcription was used as the template to amplify GRP78 gene. Bacterial expression plasmid was prepared by ligating the full-length GRP78 coding sequence into the Bam HI/Xho I sites of pGEX-4T-2. GRP78 fused to glutathione S-transferase (GST) were expressed in E.coli and purified by GST-affinity purification (Qi et al., 2010) . The isolated GST-GRP78 fusion protein was analysed by PAGE under non-denaturing conditions. 10 µg protein was subjected to different lanes of 8% polyacrylamide gel electrophoresis without SDS at 4°C with a constant current of 20 mA/gel. After electrophoresis, the gel was stained with Coomassie Brilliant Blue R-250.
Cell culture and conditioned medium collection
The colon cancer cells of DLD1, SW480, HT-29 and Lovo were cultured in RPMI-1640 medium containing 10% FBS at 37 °C in humidified tissue culture incubator containing 5% CO 2 . Conditioned medium from colon cancer cells was generated as follows: 80% of confluent cells were fed with serum-free DMEM and incubated for 24 hours. The medium was then collected, clarified by centrifugation for 30 minutes at 5, 000 rpm and concentrated by the 30-kDa MW cut-off ultrafiltration membranes (Millipore).
MTT and colony formation assays
For cell growth assay, 2000 cells were seeded into a 96-well plate and treated with purified GRP78. After 24 hours treatment, 20 µl MTT (5 mg/ml) was added to each well to reveal cell proliferation. Colony formation assay was performed as previously reported (Yue et al., 2012) . Briefly, DLD1 cells were plated onto 60 mm dishes at 5000 cells per dish and then treated with GST or GST-GRP78 respectively for 2 weeks at 37 °C. When large colonies were visible, the cells were fixed with methanol and stained with crystal violet for 20 min. The numbers of colony was counted under phase-contrast microscope.
Western blotting and GST pull down assay
The whole cell extracts, as well as the concentrated cell culture supernatants were resolved by SDS-PAGE, transferred to a PVDF membrane. After incubation with primary antibodies, blots were incubated with HRPconjugated secondary antibody for 2 hours at room temperature. The bands were visualized using an enhanced chemiluminescence detection kit and radiographic film.
For GST-pull down assay, 2×10 7 DLD1 cells were collected and all of the proteins from cell surface were extracted according to the protocol. 300 μg cell suface proteins extraction were incubated with GST and GST-GRP78 bound to glutathione-Sepharose beads for 2 hours at 4°C by gently shaking. The bound proteins were detected by SDS-PAGE silver nitrate stained analysis.
Silver nitrate staining and mass spectrometry
After electrophoresis, the gel slab was fixed in 50% methanol, 5% acetic acid in water for 20 min. It was then washed for 10 min with 50% methanol in water and another 10 min with water. The gel was sensitized by a 1 min incubation in 0.02% sodium thiosulfate. It was then rinsed with two changes of distilled water for 1 min each. After rinsing, the gel was submerged in chilled 0.1% silver nitrate solution and incubated for 20 min at 4 °C. After incubation, the silver nitrate was discarded. The gel slab was rinsed twice with water for 5 s, and then developed in 6% Na2CO3, 0.05% formalin in 0.0004% Na2S2O3 with intensive shaking. Silver-stained gels were stored in a solution of 1% acetic acid at 4°C. The spots of interest were excised from gels and subjected to mass spectrometry (Rabilloud et al., 1988; Shevchenko et al., 1996) .
Statistical analysis
Data are expressed as the mean ± SEM. Differences among groups were tested by one-way analysis of variance (ANOVA). Comparisons between two groups were evaluated using Student's t-test. A value of p<0.05 was considered statistically significant.
Results
Secreted GRP78 from colon cancer cells promotes cell proliferation
To investigate whether GRP78 could be secreted from colon cancer cells, the conditioned medium from HT-29, SW480, DLD1 and Lovo cells were collected and concentrated. As shown in Figure 1A , GRP78 was secreted by all the four types of colon cancer cells. Among them, DLD1 cells had the highest secretory capacity. Next, to assess the autocrine role of GRP78, the full length GRP78 gene was cloned, expressed and purified in E. coli ( Figure  1B ). When applied to cells in culture, GRP78 significantly promoted cell proliferation, especially in DLD1 cells, as demonstrated by the MTT assay ( Figure 1C) . The optimal concentration of GRP78 to promote DLD1 cell proliferation was at 1 μM ( Figure 1D ). Furthermore, an obvious proliferation-promoting effect was also observed using plate colony formation assay ( Figure 1E and 1F) .
Secreted GRP78 is a novel ligand of cell surface GRP78
To identify the potential signal receptor of secreted GRP78, cell membrane protein of DLD1 cell was extracted and incubated with either GST-GRP78 or GST protein, followed by GST pull down assay. The GRP78-binding proteins were then analyzed by silver staining SDS-PAGE and cut for mass spectrometry (Figure 2A) . The results indicated that the most probable binding protein of secreted GRP78 was the membrane GRP78 ( Figure  2B and Table 1 ). Furthermore, GST-GRP78 protein was likely to form a dimer itself when loaded onto a nondenaturing PAGE gel ( Figure 2C ). Moreover, blockage of cell surface GRP78 by anti-GRP78 antibody reversed the pro-proliferative effects of GST-GRP78 ( Figure 2D) . The above data indicate that secreted GRP78 is able to utilize cell surface GRP78 as its signaling receptor. 
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Secreted GRP78 activates the PI3K/Akt signaling pathway PI3K/Akt pathway is an important downstream signal of surface GRP78, mediating cell proliferation and survival (Kelber et al., 2009) . GST-GRP78 treatment also elevated the phosphorylation level of Akt ( Figure 3A ), while treatment with 30 μM LY294002, a PI3K inhibitor, significantly reversed the proliferative effect of GST-GRP78 ( Figure 3B ), suggesting that PI3K/Akt pathway is a downstream signal of secreted GRP78.
Secreted GRP78 promotes the activation of Wnt signaling
Aberrant activation of Wnt/β-catenin signaling is implicated in malignant transformation of many cell types (Valenta et al., 2012) . Activation of Akt can inactivate GSK-3β, thus promoting the stabilization of β-catenin (Mannoury la Cour et al., 2011). Our results indicated that GSK-3β was phosphorylated and inactivated by GRP78 treatment. The levels of β-catenin and its downstream target gene c-Myc were also elevated by GRP78 treatment ( Figure 4A ). Inhibition of PI3K/Akt pathway by LY294002 reversed the above effects of GRP78, indicating that activation of β-catenin by GRP78 depends on the PI3K/Akt pathway ( Figure 4B ). In addition, the G1 phase-related proteins, such as cyclin D1 and cyclin E, were also raised by GRP78 treatment, suggesting that GRP78 is likely to be implicated in regulating G1 to S progression ( Figure 4C ).
Discussion
Although the mortality rate declines in the past few years, colorectal cancer (CRC) remains the third most common malignancy and a major health problem worldwide (Zhu et al., 2013) . Though many risk factors have been reported to be related to the CRC occurrence, the detailed pathogenesis mechanism of CRC remains not fully understood. Therefore, it is urgent to explore the mechanisms underlying CRC progression for a better prevention and therapy (Xiang and Li, 2014) . Besides as a molecular chaperone in ER, GRP78 is often overexpressed in tumor cells and plays an important role in tumor cell proliferation, angiogenesis, metastasis and resistance to apoptosis. Importantly, GRP78 is also considered as a prognostic biomarker in colorectal cancer (Thornton et al., 2013) .
Recent evidence has shown that GRP78 can be secreted by a variety of bortezomib-resistant solid tumor cell lines, and blocks the antiangiogenic activity of bortezomib through activation of ERK1/2 but inhibition of p53 (Kern et al., 2009) . Whether GRP78 can be secreted from CRC cells? If so, what are the biological functions? In the present study, we demonstrate for the first time that colon cancer cell-secreted GRP78 promotes cell proliferation in an autocrine manner. Moreover, we identify the cell surface GRP78 as the signaling receptor for secreted GRP78.
GRP78 is usually expressed on tumor cell surface and functions as a receptor of different functions, depending on its binding ligands (Gonzalez-Gronow et al., 2009) . For example, ligation of surface GRP78 by α2-M* activates MAPK and Akt-dependent signaling and promotes cellular proliferation (Misra et al., 2006) , while ligation of surface GRP78 with antibodies against the C-terminal domain of GRP78 result in suppression of cell growth and induction of apoptosis (Misra et al., 2009; Misra and Pizzo, 2010a; Misra and Pizzo, 2010b) . Studies have actually shown that the PI3K/Akt signaling plays a significant role in the promotion of tumor cell proliferation and colon tumorigenesis (Zheng et al., 2012) . Activation of Akt can stabilize β-catenin by inactivation of GSK-3β or directly induce β-catenin phosphorylation, implicated in cell cycle regulation (Pandurangan, 2013) . Our study shows that ligation of surface GRP78 with secreted GRP78 also activates PI3K/Akt signaling pathway and subsequently stimulates Wnt/β-catenin pathway. Although the underlying mechanisms by which secreted GRP78 activates the PI3K/Akt signaling pathway are still unclear, it can be deduced that secreted GRP78 and α2-M* may bind to the same domain of cell surface GRP78 in order to exert their influence.
In summary, our study identifies a novel action mode of GRP78 in tumor microenvironment: tumor cellsecreted GRP78 binds to cell surface GRP78 and activates downstream PI3K/Akt signaling pathway, consequently promoting cell proliferation and survival ( Figure 4D ). Our study suggests that GRP78 secretion may a measure Western blotting analysis of cyclin D1 and cyclin E in DLD1 cells after GST-GRP78 treatment for 24 h, 48 h, respectively. (D) Schematic representation of the proposed model. Upon microenvironmental stresses, GRP78 is overexpressed and secreted into the microenvironment. The binding of secreted GRP78 to cell surface GRP78 stimulates the PI3K/Akt signaling, which concurrently activates the β-catenin signaling and promotes cell growth.
